These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 454671)
1. Preparation of a non-immunogenic arginase by the covalent attachment of polyethylene glycol. Savoca KV; Abuchowski A; van Es T; Davis FF; Palczuk NC Biochim Biophys Acta; 1979 May; 578(1):47-53. PubMed ID: 454671 [TBL] [Abstract][Full Text] [Related]
2. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. Abuchowski A; McCoy JR; Palczuk NC; van Es T; Davis FF J Biol Chem; 1977 Jun; 252(11):3582-6. PubMed ID: 16907 [TBL] [Abstract][Full Text] [Related]
3. Alteration of the circulating life and antigenic properties of bovine adenosine deaminase in mice by attachment of polyethylene glycol. Davis S; Abuchowski A; Park YK; Davis FF Clin Exp Immunol; 1981 Dec; 46(3):649-52. PubMed ID: 7337981 [TBL] [Abstract][Full Text] [Related]
4. Cancer therapy with chemically modified enzymes. II. The therapeutic effectiveness of arginase, and arginase modified by the covalent attachment of polyethylene glycol, on the taper liver tumor and the L5178Y murine leukemia. Savoca KV; Davis FF; van Es T; McCoy JR; Palczuk NC Cancer Biochem Biophys; 1984 Sep; 7(3):261-8. PubMed ID: 6488153 [TBL] [Abstract][Full Text] [Related]
5. Use of site-directed mutagenesis to enhance the epitope-shielding effect of covalent modification of proteins with polyethylene glycol. Hershfield MS; Chaffee S; Koro-Johnson L; Mary A; Smith AA; Short SA Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7185-9. PubMed ID: 1714590 [TBL] [Abstract][Full Text] [Related]
6. Preparation of a polyethylene glycol: superoxide dismutase adduct, and an examination of its blood circulation life and anti-inflammatory activity. Pyatak PS; Abuchowski A; Davis FF Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):113-27. PubMed ID: 7403670 [TBL] [Abstract][Full Text] [Related]
7. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. Abuchowski A; van Es T; Palczuk NC; Davis FF J Biol Chem; 1977 Jun; 252(11):3578-81. PubMed ID: 405385 [TBL] [Abstract][Full Text] [Related]
8. Plasma clearance and immunologic properties of long-acting superoxide dismutase prepared using 35,000 to 120,000 dalton poly-ethylene glycol. Saifer MG; Somack R; Williams LD Adv Exp Med Biol; 1994; 366():377-87. PubMed ID: 7771266 [TBL] [Abstract][Full Text] [Related]
9. Some properties of polyethylene glycol:phenylalanine ammonia-lyase adducts. Wieder KJ; Palczuk NC; van Es T; Davis FF J Biol Chem; 1979 Dec; 254(24):12579-87. PubMed ID: 91612 [TBL] [Abstract][Full Text] [Related]
10. Induction of tolerance in mice by uricase and monomethoxypolyethylene glycol-modified uricase. Savoca KV; Davis FF; Palczuk NC Int Arch Allergy Appl Immunol; 1984; 75(1):58-67. PubMed ID: 6746105 [TBL] [Abstract][Full Text] [Related]
11. Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins. Richter AW; Akerblom E Int Arch Allergy Appl Immunol; 1983; 70(2):124-31. PubMed ID: 6401699 [TBL] [Abstract][Full Text] [Related]
12. Immunologic properties of conjugates of ragweed antigen E with various alkoxypolyethylene glycols. King TP; Weiner C Int Arch Allergy Appl Immunol; 1981; 66(4):439-46. PubMed ID: 7306366 [TBL] [Abstract][Full Text] [Related]
13. Enzyme therapy: II. Effect of covalent attachment of polyethylene glycol on biochemical parameters and immunological determinants of beta-glucosidase and alpha-galactosidase. Wieder KJ; Davis FF J Appl Biochem; 1983; 5(4-5):337-47. PubMed ID: 6207160 [TBL] [Abstract][Full Text] [Related]
14. Studies on antigenicity of the polyethylene glycol (PEG)-modified uricase. Tsuji J; Hirose K; Kasahara E; Naitoh M; Yamamoto I Int J Immunopharmacol; 1985; 7(5):725-30. PubMed ID: 2412977 [TBL] [Abstract][Full Text] [Related]
15. Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase. Abuchowski A; van Es T; Palczuk NC; McCoy JR; Davis FF Cancer Treat Rep; 1979 Jun; 63(6):1127-32. PubMed ID: 466651 [TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of recombinant IL-2 modified by covalent attachment of polyethylene glycol. Katre NV J Immunol; 1990 Jan; 144(1):209-13. PubMed ID: 2295792 [TBL] [Abstract][Full Text] [Related]
17. Rational design, engineer, and characterization of a novel pegylated single isomer human arginase for arginine depriving anti-cancer treatment. Yu KM; Pang TP; Cutler M; Tian M; Huang L; Lau JY; Chung SF; Lo TW; Leung TY Life Sci; 2021 Jan; 264():118674. PubMed ID: 33129876 [TBL] [Abstract][Full Text] [Related]
18. Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy. Stone E; Chantranupong L; Gonzalez C; O'Neal J; Rani M; VanDenBerg C; Georgiou G J Control Release; 2012 Feb; 158(1):171-9. PubMed ID: 22001609 [TBL] [Abstract][Full Text] [Related]
19. Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225. Wen X; Wu QP; Ke S; Ellis L; Charnsangavej C; Delpassand AS; Wallace S; Li C J Nucl Med; 2001 Oct; 42(10):1530-7. PubMed ID: 11585869 [TBL] [Abstract][Full Text] [Related]
20. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration. Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]